Intravitreal triamcinolone acetonide for rebound phenomenon after high-dose intravenous steroid treatment in Vogt-Koyanagi-Harada disease
Ik Soo Byon1, Ji Hun Kim1, Ji Eun Lee1,2, Boo Sup Oum1,2 1Department of Ophthalmology, Pusan National University Hospital; 2Medical Institute, School of Medicine, Pusan National University, Busan, Republic of Korea Abstract: The authors report two cases of rebound phenomenon treated with intravitrea...
Guardado en:
Autores principales: | Byon IS, Kim JH, Lee JE, Oum BS |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a4f76c0134ba43c8a701b2a71892208e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Vogt–Koyanagi–Harada syndrome – current perspectives
por: Baltmr A, et al.
Publicado: (2016) -
New Perspectives on the Immunopathogenesis and Treatment of Uveitis Associated With Vogt-Koyanagi-Harada Disease
por: Ahmed M. Abu El-Asrar, et al.
Publicado: (2021) -
Clinical spectrum and management options in Vogt–Koyanagi–Harada disease
por: Lodhi SA, et al.
Publicado: (2017) -
Clinical course of focal choroidal excavation in Vogt–Koyanagi–Harada disease
por: Nishikawa Y, et al.
Publicado: (2014) -
Scleral tunnel leakage induced by injection of dexamethasone intravitreal implant for recurrent Vogt-Koyanagi-Harada disease: a case report
por: Ying Huang, et al.
Publicado: (2021)